NCT00092443已完成3 期
Study of the Efficacy, Safety, and Immunogenicity of V260 at Expiry
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 1,312
- 主要终点
- Occurence of Clinical Rotavirus Disease Caused by the Composite of the Serotypes Contained Within the Vaccine More Than 14 Days Following the Third Dose.
研究概览
简要总结
This study was designed to evaluate the safety of the investigational Rotavirus Vaccine and the efficacy to prevent Rotavirus Gastroenteritis.
详细描述
The duration of treatment is 10 months.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 6 Weeks 至 12 Weeks（Child）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Healthy infants
排除标准
- •History of abdominal disorders from a birth defect, intussusception, or abdominal surgery
- •Known or suspected problems with immune system
- •Fever at time of immunization
- •Prior administration of a rotavirus vaccine
- •History of known prior rotavirus disease
- •Chronic diarrhea, or failure to thrive
结局指标
主要结局
Occurence of Clinical Rotavirus Disease Caused by the Composite of the Serotypes Contained Within the Vaccine More Than 14 Days Following the Third Dose.
时间窗: At least 14 days following the 3rd vaccination
G1, G2, G3, and G4 Serotype Rotavirus Gastroenteritis Cases Occurring at Least 14 Days Postdose 3 Through the First Rotavirus Season Postvaccination in the Per-Protocol Population Using Per-Protocol Case Definition
次要结局
- Number of Subjects With ≥3 Fold Rise in Antibody Titer(14 days following the 3rd vaccination)
研究者
相似试验
已完成
4 期
Pilot Study of the Rotavirus Vaccine in Infants With Intestinal FailureRotavirus VaccinesIntestinal FailureNCT00995813Seattle Children's Hospital15
已完成
3 期
Rotavirus Efficacy and Safety Trial (REST)(V260-006)Rotavirus InfectionsNCT00090233Merck Sharp & Dohme LLC69,274
已完成
3 期
Efficacy, Safety and Immunogenicity of Rotavirus RV3 Vaccine (Bio Farma) in NeonatesRotavirus GastroenteritisNCT04185545PT Bio Farma1,400
撤回
不适用
Effectiveness of RotarixTM Vaccine in Children Aged Between 12 Weeks to < 5 Years, Hospitalised for Severe GastroenteritisInfections, RotavirusNCT01978223GlaxoSmithKline
已完成
不适用
Effectiveness Study of GSK Biologicals' Rotarix TM Vaccine in Hospitalized ChildrenInfections, RotavirusRotavirus VaccinesNCT01177826GlaxoSmithKline643